Inotiv Inc

FRA:BS50 (USA)  
€ 8.15 (+8.67%) Mar 18
At Loss
P/B:
0.90
Market Cap:
€ 212.12M ($ 230.66M)
Enterprise V:
€ 585.68M ($ 642.25M)
Volume:
-
Avg Vol (2M):
850.00
Also Trade In:
Volume:
-
At Loss
Avg Vol (2M):
850.00

Business Description

Description
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.
Name Current Vs Industry Vs History
Cash-To-Debt 0.05
Equity-to-Asset 0.3
Debt-to-Equity 1.69
Debt-to-EBITDA 7.27
Interest Coverage 0.12
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.28
Distress
Grey
Safe
Beneish M-Score -2.65
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 76.96
9-Day RSI 73.31
14-Day RSI 72.48
6-1 Month Momentum % 83.77
12-1 Month Momentum % 28.47

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.74
Quick Ratio 1.28
Cash Ratio 0.2
Days Inventory 53.79
Days Sales Outstanding 45.07
Days Payable 27.21

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -32.9
Shareholder Yield % -17.13

Financials (Next Earnings Date:2024-05-10 Est.)

FRA:BS50's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Inotiv Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 542.936
EPS (TTM) (€) -1.205
Beta 3.79
Volatility % 156.95
14-Day RSI 72.48
14-Day ATR (€) 0.348091
20-Day SMA (€) 6.68
12-1 Month Momentum % 28.47
52-Week Range (€) 1.57 - 8.15
Shares Outstanding (Mil) 25.79

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Inotiv Inc Filings

Filing Date Document Date Form
No Filing Data

Inotiv Inc Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Inotiv Inc Frequently Asked Questions

What is Inotiv Inc(FRA:BS50)'s stock price today?
The current price of FRA:BS50 is €8.15. The 52 week high of FRA:BS50 is €8.15 and 52 week low is €1.57.
When is next earnings date of Inotiv Inc(FRA:BS50)?
The next earnings date of Inotiv Inc(FRA:BS50) is 2024-05-10 Est..
Does Inotiv Inc(FRA:BS50) pay dividends? If so, how much?
Inotiv Inc(FRA:BS50) does not pay dividend.

Press Release

Subject Date
No Press Release